Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Short term Debt: 2018-2020

  • Neurocrine Biosciences' Short term Debt was N/A to $425.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $425.0 million, marking a year-over-year change of. This contributed to the annual value of $408.8 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q3 2020, Neurocrine Biosciences' Short term Debt is $425.0 million, which was up 1.31% from $419.5 million recorded in Q2 2020.
  • Over the past 5 years, Neurocrine Biosciences' Short term Debt peaked at $425.0 million during Q3 2020, and registered a low of $383.6 million during Q3 2018.
  • In the last 3 years, Neurocrine Biosciences' Short term Debt had a median value of $414.1 million in 2019 and averaged $409.2 million.